NCT02715024

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

An Open-label, Randomized, Parallel Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Astellas Pharma Taiwan, Inc. · Industry
• Sex: Male
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to evaluate the clinical efficacy and safety of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB) symptoms in Taiwan.

Conditions

• Lower Urinary Tract Symptoms
• Overactive Bladder
• Benign Prostatic Hyperplasia (BPH)

Interventions

Type	Name	Description
DRUG	Tamsulosin	Oral
DRUG	Solifenacin	Oral

Timeline

• Start date: 2007-09-01
• Primary completion: 2011-04-01
• Completion: 2011-04-01
• First posted: 2016-03-22
• Last updated: 2016-03-22

Locations

1 site across 1 country: Taiwan